← Eichor
Study identifier: NCT06128746 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

rTMS Treatment of Spasticity in Children With Cerebral Palsy/ Hemiplegia Due to ABI - a RCT

Condition: CP (Cerebral Palsy)  ·  Sponsor: The University of Hong Kong

PhaseNA
Planned participants20
Who can joinAll sexes, 7 Years to 18 Years
Healthy volunteersNo

About this study

This RCT aims to investigate the effect of repetitive transcranial magnatic stimulation (rTMS) in treating children with hemiplegoc cerebral palsy. The study will measure any improvement in spasticity after using contra-lesional inhibitory rTMS follow by intensive limb training. Participants will attend a 10-day rTMS treatment sessions, follow by intensive training of the impaired limb. They will also undergo MRI scans before and after the treatment to investiagte the underlying neurophysiological mechanisms that lead to changes clinically by using TMS as well as MR-DKI. Researchers will compare the intervention group and the sham group to see if rTMS could result in improvement of participants' spasticity.

This description comes directly from the study's public registry record.

Talk to the study team

Winnie Wan Yee Tso, MBBS  ·  +85222554295  ·  wytso@hku.hk

Chai Yin Charlie Fan, MPhil, OTR  ·  +85222554375  ·  charliefan@connect.hku.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Li Ka Shing Faculty of MedicineHong Kong, Hong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06128746